Patients w/ chronic active hepatitis & cirrhosis.
Patients whose ALT rises during administration of Bidica: ALT can increase after the end of administration, but it can be improved through re-administration of Bidica. Nausea may occur rarely. Pregnancy & lactation. Childn. Elderly.